The HCP should be informed of any bleeding from the IV site, gums, rectum, or vagina. Although the HCP might not be able to intervene to stop the bleeding during therapy, it is nevertheless important to let the HCP know.
Thrombolytic therapy may involve the administration of drugs to dissolve existing blood clots or stop the formation of new blood clots. Fibrinolytic treatment is another name for it. Some of these clot-busting medications are oral.
An intravenous (IV) peripheral line will be inserted into a visible vein in your arm to provide the "clot-busting" medication. carried out at your bedside in an intensive care unit while your heart and lung health are being closely watched. Until it hits the clot, the medication travels through the bloodstream.
The three thrombolytic medications alteplase, urokinase, and streptokinase are the ones that the FDA has currently approved for use in patients with acute PE.
To know more about thrombolytic therapy you may visit the link:
https://brainly.com/question/28447334
#SPJ4